[1] Thompson L. World health organization classification of tumours: Pathology and genetics of head and neck tumours [J]. Ear, nose, & throat journal, 2006, 85(2)∶74 [2] Walker D M,Boey G,Mcdonald L. The pathology of oral cancer [J]. Pathology, 2003, 35(5)∶376-383 [3] Volinia S,Calin G A,Liu C-G, et al. A microrna expression signature of human solid tumors defines cancer gene targets [J]. Proceedings of the National Academy of Sciences of the United States of America, 2006, 103(7)∶2257-2261 [4] Agirre X,Vilas-Zornoza A,Jiménez-Velasco A, et al. Epigenetic silencing of the tumor suppressor microrna hsa-mir-124a regulates cdk6 expression and confers a poor prognosis in acute lymphoblastic leukemia [J]. Cancer research, 2009, 69(10)∶4443-4453 [5] N B,Ma R,Mk L, et al. Microrna-124a regulates foxa2 expression and intracellular signaling in pancreatic beta-cell lines [J]. The Journal of Biological Chemistry, 2007, 282(27)∶19575-19588 [6] Mitchell P S,Parkin R K,Kroh E M, et al. Circulating micrornas as stable blood-based markers for cancer detection [J]. Proceedings of the National Academy of Sciences, 2008, 105(30)∶10513-10518 [7] Shi X,Xue L,Ma A, et al. Tumor suppressive mir-124 targets androgen receptor and inhibits proliferation of prostate cancer cells [J]. Oncogene, 2013, 32(35)∶4130-4138 [8] Furuta M,Kozaki K-I,Tanaka S, et al. Mir-124 and mir-203 are epigenetically silenced tumor-suppressive micrornas in hepatocellular carcinoma [J]. Carcinogenesis, 2010, 31(5)∶766-776 [9] Xie L,Zhang Z,Tan Z, et al. Microrna-124 inhibits proliferation and induces apoptosis by directly repressing ezh2 in gastric cancer [J]. Molecular and cellular biochemistry, 2014∶1-7 [10] Huang T-C,Chang H-Y,Chen C-Y, et al. Silencing of mir-124 induces neuroblastoma sk-n-sh cell differentiation, cell cycle arrest and apoptosis through promoting ahr [J]. FEBS letters, 2011, 585(22)∶3582-3586 [11] Li K K W,Pang J C-S,Ching A K-K, et al. Mir-124 is frequently down-regulated in medulloblastoma and is a negative regulator of slc16a1 [J]. Human pathology, 2009, 40(9)∶1234-1243 [12] Silber J, Hashizume R, Felix T, et al. Expression of mir-124 inhibits growth of medulloblastoma cells [J]. Neuro-oncology, 2013, 15(1)∶83-90 [13] Zeng B,Li Z,Chen R, et al. Epigenetic regulation of mir-124 by hepatitis c virus core protein promotes migration and invasion of intrahepatic cholangiocarcinoma cells by targeting smyd3 [J]. FEBS letters, 2012, 586(19)∶3271-3278 [14] 迟艳侠,李德超,南晓利,等. EZH2和P130在唾液腺腺样囊性癌中的表达及意义[J].口腔医学研究,2012,28(9)∶894-896 [15] Smits M, Nilsson J, Mir S E, et al. Mir-101 is down-regulated in glioblastoma resulting in ezh2-induced proliferation, migration, and angiogenesis [J]. Oncotarget, 2010, 1(8)∶710 |